The SDNY Patent Litigation Update provides a single-resource, monthly summary of patent litigation action in SDNY including important decisions, complaints filed, and trending issues. For example, last month Judge Rakoff refused to enhance damages for Microscan’s willful infringement of Cognex’s barcode patent, but did award attorneys’ fees. Read More >
|
Significant Decisions/Court Orders |
3 More >
|
|
Cognex Corp., et al. v. Microscan Systems, Inc., et al.
Case Number: 1:13-cv-02027-JSR
Date: June 30, 2014
Document (Dkt. 252)
Judge Rakoff Grants Permanent Injunction and Awards Attorneys’ Fees for Unreasonable Litigation Tactics and Redundant Post-Trial Motions, But Does Not Enhance Damages for Willful Infringement. More >
|
Realtime Data, LLC d/b/a IXO v. CME Group, Inc.
Case Number: 1:11-cv-06697-KBF
Date: June 24,2014
Document (Dkt. 921)
Judge Forrest Denies Attorneys’ Fees and Ancillary Electronic Discovery Costs. More >
|
CDX Diagnostics, Inc., et al. v. US Endoscopy Group, Inc., et al.
Case Number: 7:13-cv-05669-NSR
Date: June 20, 2014
Document (Dkt. 23)
Request for Stay Pending Before Institution of Inter Partes Review Denied.
More >
|
|
Date Filed
|
Case Number
|
Plaintiff(s)
|
Defendant(s)
|
Patent Number(s)
|
Accused Product(s)
|
6/2/2014 |
1:14-cv-03928-RJS |
Gilead Sciences, Inc.; Emory University |
Mylan, Inc.; Mylan Pharmaceuticals, Inc. |
6,642,245 (“Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane”); 6,703,396 (“Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers”); 8,592,397 (“Compositions and methods for combination antiviral therapy”)
|
Tablets containing the combination of 200 mg of emtricitabine and 300 mg of tenofovir disoproxil fumarate |
6/6/2014 |
1:14-cv-04119-JMF
|
Thrillist Media Group, Inc |
Eclipse IP LLC
|
8,564,459 (“Systems and methods for a notification system that enable user changes to purchase order information for delivery and/or pickup of goods and/or services”)
|
Jackthreads.com online ordering platform (Product named in declaratory judgment action seeking invalidation of ’459 patent and declaration of non-infringement)
|
6/10/2014 |
1:14-cv-04161-PGG
|
Naraka, LLC |
ooVoo LLC d/b/a ooVoo
|
8,112,490 (“System and method for providing a virtual environment with shared video on demand”)
|
Shared Video on Demand technology
|
|
|